clinical trial · NCT07323680
Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Subjects
Rhoshan Pharmaceuticals Inc·phase1·completed·n = 40
Healthy325 mg Oral Aspirin325 mg aspirin by rapid IV push
brief summary
The purpose of this study is to compare the safety, pharmacokinetics, and pharmacodynamic effects of aspirin administered intravenously with aspirin administered orally.
started
Jun 15, 2025
primary completion
Jul 7, 2025
completion
Dec 12, 2025
last updated
Jun 12, 2026
official title
A Phase 1, Open-Label, 2-Period, 2-Formulation, Within-Subject Crossover Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose Level of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Human Subjects Under Fasting Conditions.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol